Behavioural Neurology

Behavioural Neurology / 1999 / Article

Open Access

Volume 11 |Article ID 327643 | https://doi.org/10.1155/1999/327643

Aileen K. Ho, Robert Iansek, Caterina Marigliani, John L. Bradshaw, Sandra Gates, "Speech Impairment in a Large Sample of Patients with Parkinson’s Disease", Behavioural Neurology, vol. 11, Article ID 327643, 7 pages, 1999. https://doi.org/10.1155/1999/327643

Speech Impairment in a Large Sample of Patients with Parkinson’s Disease

Received01 Feb 1999
Accepted01 Feb 1999

Abstract

This study classified speech impairment in 200 patients with Parkinson’s disease (PD) into five levels of overall severity and described the corresponding type (voice, articulation, fluency) and extent (rated on a five-point scale) of impairment for each level. From two-minute conversational speech samples, parameters of voice, fluency and articulation were assessed by two trained-raters. Voice was found to be the leading deficit, most frequently affected and impaired to a greater extent than other features in the initial stages. Articulatory and fluency deficits manifested later, articulatory impairment matching voice impairment in frequency and extent at the ‘Severe’ stage. At the final stage of `Profound' impairment, articulation was the most frequently impaired feature at the lowest level of performance. This study illustrates the prominence of voice and articulatory speech motor control deficits, and draws parallels with deficits of motor set and motor set instability in skeletal controls of gait and handwriting.

Copyright © 1999 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views391
Downloads2976
Citations

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.